CoChat

Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders

Open access

The DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index; 57 of the 135 sources its claims cite were checked for support.

Abstract

The behavioural variant of frontotemporal dementia (bvFTD) is a frequent cause of early-onset dementia. The diagnosis of bvFTD remains challenging because of the limited accuracy of neuroimaging in the early disease stages and the absence of molecular biomarkers, and therefore relies predominantly on clinical assessment. BvFTD shows significant symptomatic overlap with non-degenerative primary psychiatric disorders including major depressive disorder, bipolar disorder, schizophrenia, obsessive-compulsive disorder, autism spectrum disorders and even personality disorders. To date, ∼50% of patients with bvFTD receive a prior psychiatric diagnosis, and average diagnostic delay is up to 5-6 years from symptom onset. It is also not uncommon for patients with primary psychiatric disorders to be wrongly diagnosed with bvFTD. The Neuropsychiatric International Consortium for Frontotemporal Dementia was recently established to determine the current best clinical practice and set up an international collaboration to share a common dataset for future research. The goal of the present paper was to review the existing literature on the diagnosis of bvFTD and its differential diagnosis with primary psychiatric disorders to provide consensus recommendations on the clinical assessment. A systematic literature search with a narrative review was performed to determine all bvFTD-related diagnostic evidence for the following topics: bvFTD history taking, psychiatric assessment, clinical scales, physical and neurological examination, bedside cognitive tests, neuropsychological assessment, social cognition, structural neuroimaging, functional neuroimaging, CSF and genetic testing. For each topic, responsible team members proposed a set of minimal requirements, optimal clinical recommendations, and tools requiring further research or those that should be developed. Recommendations were listed if they reached a ≥ 85% expert consensus based on an online survey among all consortium participants. New recommendations include performing at least one formal social cognition test in the standard neuropsychological battery for bvFTD. We emphasize the importance of 3D-T1 brain MRI with a standardized review protocol including validated visual atrophy rating scales, and to consider volumetric analyses if available. We clarify the role of 18F-fluorodeoxyglucose PET for the exclusion of bvFTD when normal, whereas non-specific regional metabolism abnormalities should not be over-interpreted in the case of a psychiatric differential diagnosis. We highlight the potential role of serum or CSF neurofilament light chain to differentiate bvFTD from primary psychiatric disorders. Finally, based on the increasing literature and clinical experience, the consortium determined that screening for C9orf72 mutation should be performed in all possible/probable bvFTD cases or suspected cases with strong psychiatric features.

Overview

CoChat Summary

TL;DR

This consensus review from the Neuropsychiatric International Consortium for Frontotemporal Dementia summarizes evidence and expert recommendations for distinguishing behavioural variant frontotemporal dementia (bvFTD) from primary psychiatric disorders (PPD). It recommends formal social cognition testing, standardized 3D-T1 MRI review, cautious FDG-PET interpretation, consideration of neurofilament light chain, and C9orf72 screening in possible/probable bvFTD or suspected cases with strong psychiatric features.

Key findings

  • bvFTD is frequently misdiagnosed: around 50% of patients receive a prior psychiatric diagnosis, average diagnostic delay is up to 5–6 years from symptom onset, possible bvFTD criteria had poor specificity (27%) in a mixed neuropsychiatric cohort, standard MRI sensitivity was 70%, and FDG-PET specificity was 68% because of frequent non-specific abnormalities in PPD.
  • New or emphasized recommendations include at least one formal social cognition test in the standard neuropsychological battery for bvFTD; 3D-T1 brain MRI with a standardized review protocol and validated visual atrophy rating scales, considering volumetric analyses if available; FDG-PET to support exclusion when normal, while non-specific regional hypometabolism should not be over-interpreted in a psychiatric differential diagnosis; consideration of serum or CSF neurofilament light chain (NfL) where reference values are available; and C9orf72 screening in all possible/probable bvFTD cases or suspected cases with strong psychiatric features.
  • Biomarker evidence cited: CSF NfL discriminated bvFTD from PPD with an AUC of 0.93 in a study of 22 bvFTD and 25 PPD patients; plasma NfL showed AUCs of 0.89–0.94 against schizophrenia, depression, and bipolar disorder, and 0.83 in a larger study of 66 bvFTD and 34 PPD patients; CSF NfL discriminated FTD mutation carriers from controls with an AUC of 0.99.
  • Clinical scales and cognitive tests have mixed utility: the Frontal Behavioral Inventory overall score does not distinguish bvFTD from PPD, but a positive FBI subscale score >12 was indicative of bvFTD in late-onset behavioural changes; MMSE was unsuccessful for discrimination; MoCA had 88% classification accuracy for brief cognitive screening but uncertain value against PPD; the Institute of Cognitive Neurology Frontal Screening may have discriminatory power; and a meta-analysis indicated social cognition impairment in bvFTD is more severe than in major psychiatric and developmental disorders.

Methods

  • Systematic literature search in Medline (PubMed) and Embase, completed September 2017, retrieving articles from 1992 to 2017, with relevant later references allowed; topics included bvFTD history taking, psychiatric assessment, clinical scales, physical/neurological examination, bedside cognitive tests, neuropsychological assessment, social cognition, structural and functional neuroimaging, CSF, and genetic testing.
  • Each topic was assigned to two to three NIC-FTD members based on expertise; teams reviewed abstracts and proposed minimal requirements, clinical recommendations, and tools requiring further research; an in-person meeting was held in Sydney on 13 November 2018, followed by two rounds of draft review and teleconferences.
  • Final consensus was obtained through an online survey of all co-authors, with ≥85% approval required to include recommendations.

Limitations

  • The paper states that diagnostic methods useful for distinguishing bvFTD from other dementias, such as clinical scales and cognitive tests, do not fare as well against PPD; some patients remain diagnostically ambiguous despite optimal clinical investigation, so longitudinal follow-up often becomes the diagnostic arbiter until pathology is available; non-progressive bvFTD phenocopy cases are particularly challenging, with small sample studies and some showing no FTLD pathological changes.
  • The paper states a need for better prognostic tools; CSF biomarkers require study in larger, ideally pathologically and/or genetically confirmed bvFTD cohorts; volumetric and machine-learning MRI methods lack replication and prospective validation at the individual subject level; and many social cognition instruments lack normative data and transcultural adaptation.
  • Evident from the text: the recommendations are consensus-based (≥85% expert approval) rather than prospectively validated, and many cited diagnostic accuracy estimates come from small or single studies; the systematic search ended in September 2017, with later references added non-systematically.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/brain/awaa018

Cites

203 of 203 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

36 Valid · 11 Not valid · 43 Not checked · 11 Own results and interpretations

60 more claims · 26 with their cited sources checked

Create a free account to see all 101 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 26
  • Probably not a substantial claim. 10

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

6 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Items 201–203 of 203

Research works printed but not linked: 1

  1. Cerami, 2014, Optimized objective SPM analysis improves accuracy of [18F]FDG-PET imaging in dementia diagnosis, Eur J Neurol, 21, 303

Cited by

See all 328

Metadata

Authors
Ducharme, S., Dols, A., Laforce, R., Devenney, E., Kumfor, F., van den Stock, J., Dallaire-Théroux, C., Seelaar, H., Gossink, F., Vijverberg, E., Huey, E., Vandenbulcke, M., Masellis, M., Trieu, C., Onyike, C., Caramelli, P., de Souza, L. C., Santillo, A., Waldö, M. L., Landin-Romero, R., Piguet, O., Kelso, W., Eratne, D., Velakoulis, D., Ikeda, M., Perry, D., Pressman, P., Boeve, B., Vandenberghe, R., Mendez, M., Azuar, C., Levy, R., Le Ber, I., Baez, S., Lerner, A., Ellajosyula, R., Pasquier, F., Galimberti, D., Scarpini, E., van Swieten, J., Hornberger, M., Rosen, H., Hodges, J., Diehl-Schmid, J., & Pijnenburg, Y.
Affiliations
  • Montreal Neurological Institute and Hospital (CA)
  • Amsterdam Neuroscience (NL)
  • Université Laval (CA)
  • The University of Sydney (AU)
  • Laboratory for Translational Neuropsychiatry, Department of Neurosciences, KU Leuven, Leuven, Belgium
  • CERVO brain Research Centre, Laval University, Quebec, Canada
  • Erasmus MC (NL)
  • Columbia University (US)
  • Universitair Ziekenhuis Leuven (BE)
  • Sunnybrook Health Science Centre (CA)
  • Johns Hopkins University (US)
  • Universidade Federal de Minas Gerais (BR)
  • Behavioral and Cognitive Neurology Research Group, Department of Internal Medicine, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
  • Lund University (SE)
  • Brain and Mind Centre, University of Sydney, Sydney, Australia
  • The Royal Melbourne Hospital (AU)
  • The University of Osaka (JP)
  • University of California, San Francisco (US)
  • University of Colorado Denver (US)
  • Mayo Clinic (US)
  • University of California, Los Angeles (US)
  • Pitié-Salpêtrière Hospital (FR)
  • Department of Neurology, Hôpital La Pitié Salpêtrière, Paris, France
  • Department of Psychology, Andes University, Bogota, Colombia
  • University Hospitals of Cleveland (US)
  • Manipal Hospital (IN)
  • Inserm (FR)
  • University of Milan (IT)
  • Department of Neurology, Erasmus University Medical Centre, Rotterdam, The Netherlands
  • Department of Medicine, Norwich Medical School, Norwich, UK
  • Department of Psychiatry and Psychotherapy, Technical University of Munich, School of Medicine, Munich, Germany
Corresponding author
Ducharme, Simon
Venue
Brain
Published
2020-03-04
Volume
143
Issue
6
Pages
1632-1650
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W3009452141
Cited by
320
References
202
Citations by year
2026: 39 · 2025: 53 · 2024: 64 · 2023: 56 · 2022: 57 · 2021: 43 · 2020: 7
FWCI
6.76
Type
journal article
Language
en
Open access
Locations
  • Brain (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • Lirias (submittedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • UEA Digital Repository (University of East Anglia) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
  • Fond de Recherche du Québec–Santé
  • NIH
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Social Sciences › Psychology › Clinical Psychology › Historical and Modern Theater Studies
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
behavioral variant frontotemporal dementia, differential diagnosis, mental illness, delayed diagnosis, clinical evaluation, FDG-PET, neurofilament light chain, neuropsychological assessment
MeSH terms
Mental Disorders, Diagnosis, Differential, Female, Humans, Magnetic Resonance Imaging, Male, Neurologic Examination, Neuropsychological Tests, Fluorodeoxyglucose F18, Positron-Emission Tomography, Frontotemporal Dementia, Delayed Diagnosis, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.